tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA

Sinovac Biotech (SVA) Balance Sheet

112 Followers

Sinovac Biotech Balance Sheet

Sinovac Biotech's total assets for Q4 2022 were $14.11B, a decrease of -6.31% from the previous quarter. SVA total liabilities were $1.40B for the fiscal quarter, a 44.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 14.11B$ 16.75B$ 1.90B$ 452.30M$ 369.78M
Total Liabilities
$ 1.40B$ 2.87B$ 781.20M$ 100.10M$ 77.85M
Total Equity Gross Minority
$ 12.71B$ 13.88B$ 1.12B$ 352.19M$ 291.93M
Total Capitalization
$ 9.47B$ 9.98B$ 754.76M$ 295.45M$ 264.03M
Preferred Stock Equity
--$ 15.00K$ 15.00K-
Capital Lease Obligations
--$ 89.00M$ 6.29M$ 0.00
Currency in USD

Sinovac Biotech Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis